Phase II trial of weekly gemcitabine and docetaxel combination therapy for relapsed ovarian or peritoneal cancer
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 22 Feb 2017 Status changed from active, no longer recruiting to completed.
- 16 Mar 2016 Status changed from completed to active, no longer recruiting, according to ClinicalTrials.gov record.
- 08 Feb 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.